Perspectives on human perinatal renal tract disease

Area of Science:

• Pediatric Nephrology
• Fetal Medicine
• Medical Genetics

Background:

• Perinatal renal tract disease is the primary cause of end-stage renal failure in children.
• These conditions can lead to significant long-term morbidity, including hypertension.
• Current understanding of fetal diagnosis accuracy and lifetime outcomes for affected children is limited.

Purpose of the Study:

• To highlight the need for prospective trials evaluating existing therapies for protecting long-term kidney function.
• To address uncertainties in prenatal diagnosis of renal tract disorders.
• To explore the role of genetics in congenital renal malformations.

Main Methods:

• Review of current understanding and uncertainties in perinatal renal tract disease.
• Identification of the need for prospective clinical trials.
• Discussion of emerging genetic research in renal malformations.

Main Results:

• Existing therapies like prenatal surgical decompression and postnatal drugs require efficacy trials for long-term kidney protection.
• Specific drugs targeting renal cyst growth are under human investigation.
• Genetic mutations are increasingly identified as causes for renal tract malformations.

Conclusions:

• Prospective trials are essential to determine the long-term benefits of current and experimental treatments for perinatal renal tract disease.
• Advances in genetics offer explanations for congenital kidney disorders.
• Improved understanding and management are crucial for improving outcomes in affected children.